References
- Bachmann K. Screening for the influence of host factors on warfarin clearance using a single dose, single sample procedure. International Journal of Clinical Pharmacology Therapy and Toxicology 1986; 24: 167–170
- Bachmann K. Estimating the clearance of amylobarbitone from a single plasma measurement. British Journal of Clinical Pharmacology 1987; 23: 94–98
- Bachmann K., Schwartz J., Forney R., Jr., Jauregui L. Theophylline kinetics: dose dependency and single sample prediction of clearance. Pharmacology 1985a; 30: 136–144
- Bachmann K., Schwartz J., Forney R., Jr., Jauregui L. Phenytoin as a probe of drug metabolism: predicting clearance with a salivary sample. Pharmacology 1985b; 30: 145–152
- Bachmann K., Schwartz J., Sullivan T., Jauregui L. Single sample estimate of ethosuximide clearance. International Journal of Clinical Pharmacology Therapy and Toxicology 1986; 10: 546–550
- Dandliker W., Kelly R. Fluorescence polarization immunoassay: Theory and experimental method. Immunochemistry 1973; 10: 219–227
- Dossing M. Changes in hepatic microsomal enzyme function in workers exposed to mixtures of chemicals. Clinical Pharmacology and Therapeutics 1982; 32: 340–346
- Dossing M., Poulsen H., Andreasen P. B., Tygstrup N. A simple method for determination of antipyrine clearance. Clinical Pharmacology and Therapeutics 1982; 32: 392–396
- Dossing M., Skinhoj P. Occupational liver injury: Present state of knowledge and further perspective. International Archives for Occupational and Environmental Health 1985; 56: 1–21
- Dossing M., Volund A., Poulsen H. Optimal sampling times for minimum variance of clearance determination. British Journal of Clinical Pharmacology 1983; 15: 231–235
- Iversen P., Franklin M. Microsomal cytochrome P-450 ‘handprints’: Five fractions from anion-exchange high-pressure liquid chromatography provide a rapid preliminary screen for selectivity in the induction and destruction of rat hepatic cytochrome P-450 subpopulations. Toxicology and Applied Pharmacology 1985; 78: 1–9
- Jolley M. Fluorescence polarization immunoassay for the determination of therapeutic drug levels in human plasma. Journal of Analytical Toxicology 1981; 5: 236–240
- Jusko W. J. Guidelines for collection and analysis of pharmacokinetic data. Applied Pharmacokinetics, W. Evans, J. Schentag, W. J. Jusko. Applied Therapeutics, Spokane 1986; 9–54
- Pilsgaard H., Poulsen H. A one sample method for antipyrine clearance determination in rats. Pharmacology 1984; 29: 110–116
- Sheiner L., Beal S. Some suggestions for measuring predictive performance. Journal of Pharmacokinetics and Biopharmaceutics 1981; 9: 503–512
- Slattery J., Gibaldi M., Koup J. Prediction of maintenance dose required to attain a desired drug concentration at steady-state from a single determination of concentration after an initial dose. Clinical Pharmacokinetics 1980; 5: 377–385
- Sonne J., Dossing M., Loft S., Andreasen P. B. Antipyrine clearance in pneumonia. Clinical Pharmacology and Therapeutics 1985; 37: 701–704
- Ueland P., Kvalheim G., Lonning P., Kvinnsland S. Determination of warfarin in human plasma by high performance liquid chromatography and photodiode array detector. Therapeutic Drug Monitoring 1985; 7: 329–335
- Umeda T., Inaba T. Effects of anaesthetics on diphenylhydantoin metabolism in the rat: possible inhibition by diethyl ether. Canadian Journal of Physiology and Pharmacology 1978; 56: 241–244
- Van DER Graaff M., Vermeulen N., Heij P., De Bree H., Breimer D. Correlation between the metabolism of hexobarbital and aminopyrine in vivo in rats. Xenobiotica 1986; 16: 1091–1096
- Vesell E. The antipyrine test in clinical pharmacology: conceptions and misconceptions. Clinical Pharmacology and Therapeutics 1979; 26: 275–286